Celgene Corp.
(NASDAQ : CELG)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.41%202.721.3%$426.59m
BIIBBiogen Inc.
-2.46%220.061.3%$391.11m
GILDGilead Sciences, Inc.
-0.49%64.910.9%$378.65m
CELGCelgene Corporation
1.13%102.951.3%$367.47m
ILMNIllumina, Inc.
-0.36%309.443.5%$247.45m
REGNRegeneron Pharmaceuticals, Inc.
-0.46%300.192.6%$218.58m
EXASExact Sciences Corporation
-0.95%96.4724.1%$199.33m
VRTXVertex Pharmaceuticals Incorporated
-0.84%176.231.9%$176.44m
ALXNAlexion Pharmaceuticals, Inc.
-1.58%98.412.0%$169.95m
AAgilent Technologies, Inc.
-0.44%74.591.6%$143.57m
SRPTSarepta Therapeutics, Inc.
-1.91%85.7714.6%$132.47m
BMRNBioMarin Pharmaceutical Inc.
1.84%69.154.3%$96.30m
SGENSeattle Genetics, Inc.
1.70%87.406.2%$95.18m
NKTRNektar Therapeutics
-2.81%17.275.5%$84.77m
ALDRAlder Biopharmaceuticals, Inc.
0.11%18.9210.2%$81.63m

Company Profile

Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include REVLIMID, POMALYST, IMNOVID, OTEZLA, ABRAXANE, and VIDAZA. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ.